Pediatric rhabdomyosarcoma in India: A single-center experience

[1]  L. Mariani,et al.  The Sooner the Better? How Symptom Interval Correlates With Outcome in Children and Adolescents With Solid Tumors: Regression Tree Analysis of the Findings of a Prospective Study , 2016, Pediatric Blood & Cancer.

[2]  H. Xiong,et al.  Clinical characteristics and prognosis of childhood rhabdomyosarcoma: a ten-year retrospective multicenter study. , 2015, International journal of clinical and experimental medicine.

[3]  A. Look,et al.  Nathan and Oski's hematology and oncology of infancy and childhood / , 2015 .

[4]  T. Soe,et al.  Singapore rhabdomyosarcoma (RMS) experience: shall we change our practice? , 2014, Annals of the Academy of Medicine, Singapore.

[5]  Silvia Rossi,et al.  Childhood cancer survival in Europe 1999-2007: results of EUROCARE-5--a population-based study. , 2014, The Lancet. Oncology.

[6]  A. Sachdeva,et al.  Encouraging Treatment Outcomes of Pediatric Rhabdomyosarcoma: A Developing World Experience , 2012, Pediatric hematology and oncology.

[7]  D. Hawkins,et al.  Rhabdomyosarcoma: Review of the Children's Oncology Group (COG) soft‐tissue Sarcoma committee experience and rationale for current COG studies , 2012, Pediatric blood & cancer.

[8]  H. Tamim,et al.  Rhabdomyosarcoma Treatment and Outcome at a Multidisciplinary Pediatric Cancer Center in Lebanon , 2012, Pediatric hematology and oncology.

[9]  T. Eden,et al.  Understanding refusal and abandonment in the treatment of childhood cancer , 2010, Indian pediatrics.

[10]  L. Mariani,et al.  The symptom interval in children and adolescents with soft tissue sarcomas , 2009, Cancer.

[11]  S. Ognjanovic,et al.  Trends in childhood rhabdomyosarcoma incidence and survival in the United States, 1975‐2005 , 2009, Cancer.

[12]  A. Ferrari,et al.  Comparing adult and pediatric rhabdomyosarcoma in the surveillance, epidemiology and end results program, 1973 to 2005: an analysis of 2,600 patients. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  I. Kim,et al.  Initial response to treatment was highly associated with the prognosis of childhood rhabdomyosarcoma: a retrospective analysis of a single center experience in Korea. , 2008, Cancer research and treatment : official journal of Korean Cancer Association.

[14]  L. Chirdan,et al.  Clinical characteristics and outcome of surgical treatment of childhood rhabdomyosarcoma: a 7-year experience. , 2008, African journal of paediatric surgery : AJPS.

[15]  T. Eden,et al.  The problem of treatment abandonment in children from developing countries with cancer , 2007, Pediatric blood & cancer.

[16]  B. Bernardi,et al.  Rhabdomyosarcoma in infants younger than one year old , 2003, Cancer.

[17]  James R. Anderson,et al.  Rhabdomyosarcoma and Undifferentiated Sarcoma in the First Two Decades of Life: A Selective Review of Intergroup Rhabdomyosarcoma Study Group Experience and Rationale for Intergroup Rhabdomyosarcoma Study V , 2001, Journal of pediatric hematology/oncology.

[18]  E. Gehan,et al.  The intergroup rhabdomyosarcoma study‐II , 1993, Cancer.

[19]  P. Pizzo,et al.  Principles and Practice of Pediatric Oncology , 1989 .